Peter Brenders was appointed Canadian General Manager at Sanofi Genzyme in 2012. He was President & CEO of BIOTECanada for almost eight years prior. Before then, Peter worked in senior management roles in health and corporate affairs at Genzyme and Schering- Plough Canada. Peter has also worked in the Ontario Ministry of Health and in the health consulting practice at KPMG. Peter was inducted in to the Canadian Healthcare Marketing Hall of Fame in 2016. Peter is currently a member of the board of directors of VIDO-InterVac and The Cameron Institute. He has served as a member of the board of Research Canada, the federal Department of Foreign Affairs Trade and Development's Life Sciences Advisory Group, the Advisory Board for the National Research Council's (NRC) Institute for Marine Biosciences and the NRC's Institute for Nutrisciences and Health, the Canadian Agri-Food Policy Institute Advisory Board, and was an Industry Advisor for the Atlantic Canada Opportunity Agency's Atlantic Innovation Fund Committees for Aquaculture and Biotechnology Sector and Health and Medical Sector. Peter has also been a member of the Advisory Council for Algonquin College's biotechnology program, a member of the Privy Council Office's Reference Group on Regulating, a Board member and Treasurer of the Registered Nurses Association of Ontario Foundation, and has served as the Chair of its Toronto Chapter of the Canadian College of Health Services Executives. Peter received his MBA, in Health Services Management from McMaster University. Prior to his brief work in basic research at the Robarts Research Institute, he received his Honours BSc in Pharmacology and Toxicology from the University of Western Ontario.